Related Experiment Video

Updated: Aug 19, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.2K

Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer

Jong Hyun Kim1, Chan-Hyeong Lee2, Moon-Chang Baek3

  • 1Department of Biochemistry, School of Medicine, Daegu Catholic University, Daegu, 42472, South Korea.

Experimental & Molecular Medicine
|November 29, 2022
PubMed

Insights

Exosomes, tiny cell-released vesicles, are key in cancer communication. Inhibiting exosome release offers a promising strategy for slowing cancer progression and developing new therapies.

Area of Science:

  • Cancer Biology
  • Cellular Communication
  • Extracellular Vesicles

Background:

  • Exosomes are extracellular vesicles released by various cell types.
  • They act as mediators in physiological and pathological conditions, including cancer.
  • Understanding exosome function is crucial for cancer research.

Purpose of the Study:

  • To review exosome inhibitors.
  • To discuss their mechanisms of action.
  • To evaluate their therapeutic potential in cancer treatment.

Main Methods:

  • Literature review of exosome inhibitors.
  • Analysis of exosome biogenesis and release pathways.
  • Discussion of preclinical and clinical research on exosome inhibitors.

Main Results:

  • Exosome release can be blocked by specific inhibitors.
  • These inhibitors show potential as research tools and therapeutic agents.
  • Targeting exosome pathways may offer novel cancer treatment strategies.

Conclusions:

  • Exosome inhibitors represent a promising area for cancer therapy development.
  • Further research is needed to optimize their use in clinical settings.
  • Blocking exosome communication could be a breakthrough in treating various cancers.

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.3K
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.3K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K